Your browser doesn't support javascript.
loading
CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma.
Yamaguchi, Junya; Ohka, Fumiharu; Lushun, Chalise; Motomura, Kazuya; Aoki, Kosuke; Takeuchi, Kazuhito; Nagata, Yuichi; Ito, Satoshi; Mizutani, Nobuhiko; Ohno, Masasuke; Suzaki, Noriyuki; Takasu, Syuntaro; Seki, Yukio; Kano, Takahisa; Wakabayashi, Kenichi; Oyama, Hirofumi; Kurahashi, Shingo; Tanahashi, Kuniaki; Hirano, Masaki; Shimizu, Hiroyuki; Kitano, Yotaro; Maeda, Sachi; Yamazaki, Shintaro; Wakabayashi, Toshihiko; Kondo, Yutaka; Natsume, Atsushi; Saito, Ryuta.
Afiliación
  • Yamaguchi J; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ohka F; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Lushun C; Department of Neurosurgery, Nagoya Central Hospital, Nagoya, Japan.
  • Motomura K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Aoki K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Takeuchi K; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nagata Y; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Ito S; Department of Neurosurgery, Konan Kosei Hospital, Konan, Japan.
  • Mizutani N; Department of Neurosurgery, Konan Kosei Hospital, Konan, Japan.
  • Ohno M; Department of Neurosurgery, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Suzaki N; Department of Neurosurgery, Nagoya Medical Center, Nagoya, Japan.
  • Takasu S; Department of Neurosurgery, Nagoya Medical Center, Nagoya, Japan.
  • Seki Y; Department of Neurosurgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
  • Kano T; Department of Neurosurgery, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
  • Wakabayashi K; Department of Neurosurgery, Anjo Kosei Hospital, Anjo, Japan.
  • Oyama H; Department of Neurosurgery, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Kurahashi S; Department of Neurosurgery, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Tanahashi K; Department of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Hirano M; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Shimizu H; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kitano Y; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Maeda S; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yamazaki S; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Wakabayashi T; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kondo Y; Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Natsume A; Department of Neurosurgery, Nagoya Kyoritsu Hospital, Nagoya, Japan.
  • Saito R; Division of Cancer Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Cancer Med ; 12(6): 7116-7126, 2023 03.
Article en En | MEDLINE | ID: mdl-36478416
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Neoplasias del Sistema Nervioso Central Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Neoplasias del Sistema Nervioso Central Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos